Serum hepcidin and prohepcidin concentrations in inflammatory bowel disease

European Journal of Gastroenterology and Hepatology

Volumn 23, Issue 3, 2011, Pages 262-268

  Oustamanolakis, Pantelis ^a   Koutroubakis, Ioannis E ^a   Messaritakis, Ippokratis ^a   Malliaraki, Niki ^a   Sfiridaki, Aekaterini ^b   Kouroumalis, Elias A ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b Venizelion General Hospital   (Greece)

Author keywords

anemia; Crohn's disease; hepcidin; iron deficiency; prohepcidin; ulcerative colitis

Indexed keywords

C REACTIVE PROTEIN; FERRITIN; HEMOGLOBIN; HEPCIDIN; PROHEPCIDIN;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; BLOOD CELL COUNT; CONTROLLED STUDY; CROHN DISEASE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FERRITIN BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON DEFICIENCY ANEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; ANEMIA; ANTI-INFLAMMATORY AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; AZATHIOPRINE; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DRUG COMBINATIONS; ENZYME INHIBITORS; FEMALE; GASTROINTESTINAL AGENTS; GLUCOSAMINE; HUMANS; INFLAMMATORY BOWEL DISEASES; IRON; MALE; METHOTREXATE; MIDDLE AGED; PROTEIN PRECURSORS; SMOKING; SULFASALAZINE; YOUNG ADULT;

EID: 79951954623     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328343b885     Document Type: Article

References (33)

1. Gasche C, Lomer MCE, Cavill I, Weiss G. Iron, anemia, and inflammatory bowel diseases. Gut 2004; 53:1190-1197. (Pubitemid 38961976)
2. Wells CW, Lewis S, Barton JR, Corbett S. Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis 2006; 12:123-130.
3. Bergamaschi G, Di Sabatino A, Albertini R, Ardizzone S, Biancheri P, Bonetti E, et al. Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-alpha treatment. Haematologica 2010; 95:199-205.
4. Gomollón F, Gisbert JP. Anaemia and inflammatory bowel diseases. World J Gastroenterol 2009; 15:4659-4665.
5. Weiss G, Gasche C. Pathogenesis and treatment of anemia in inflammatory bowel disease. Haematologica 2010; 95:175-178.
6. Gasche C, Berstad A, Befrits R, Beglinger C, Dignass A, Erichsen K, et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis 2007; 13:1545-1553.
7. Tsiolakidou G, Koutroubakis IE. Stimulating erythropoiesis in inflammatory bowel disease anemia. World J Gastroenterol 2007; 13:4798-4806. (Pubitemid 47496743)
8. Hugman A. Hepcidin: an important new regulator of iron homeostasis. Clin Lab Haematol 2006; 28:75-83.
9. Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001; 276:7806-7810.
10. Krause A, Neitz S, Mägert HJ, Schulz A, Forssmann WG, Schulz-Knappe P, et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 2000; 480:147-150.
11. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004; 306:2090-2093. (Pubitemid 40007660)
12. Delaby C, Pilard N, Gonçalves AS, Beaumont C, Canonne-Hergaux F. Presence of the iron exporter ferroportin at the plasma membrane of macrophages is enhanced by iron loading and down-regulated by hepcidin. Blood 2005; 106:3979-3984. (Pubitemid 41739041)
13. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003; 102:783-788. (Pubitemid 36917762)
14. Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 2001; 276:7811-7819.
15. Kemna E, Tjalsma H, Laarakkers C, Nemeth E, Willems H, Swinkels D. Novel urine hepcidin assay by mass spectrometry. Blood 2005; 106:3268-3270. (Pubitemid 41565929)
16. Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 2002; 110:1037-1044.
17. Sasu BJ, Li H, Rose MJ, Arvedson TL, Doellgast G, Molineux G. Serum hepcidin but not prohepcidin may be an effective marker for anemia of inflammation (AI). Blood Cells Mol Dis 2010; 45:238-245.
18. Semrin G, Fishman DS, Bousvaros A, Zholudev A, Saunders AC, Correia CE, et al. Impaired intestinal iron absorption in Crohn's disease correlates with disease activity and markers of inflammation. Inflamm Bowel Dis 2006; 12:1101-1106.
19. Arnold J, Sangwaiya A, Bhatkal B, Geoghegan F, Busbridge M. Hepcidin and inflammatory bowel disease: dual role in host defence and iron homoeostasis. Eur J Gastroenterol Hepatol 2009; 21:425-429.
20. Kaya Z, Yildiz E, Gursel T, Albayrak M, Kocak U, Karadeniz C, et al. Serum Prohepcidin levels in children with solid tumors, inflammatory bowel disease and iron deficiency anaemia. J Trop Pediatr 2010. [Epub ahead of print]
21. Nagy J, Lakner L, Poor V, Pandur E, Mozsik G, Miseta A, et al. Serum prohepcidin levels in chronic inflammatory bowel diseases. J Crohns Colitis 2010; 4:649-653.
22. Stange EF, Travis SP, Vermeire S, Beglinger C, Kupcinkas L, Geboes K, et al. European Crohn's and Colitis Organisation. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut 2006; 55:i1-i15.
23. Stange EF, Travis SPL, Vermeire S, Reinisch W, Geboes K, Barakauskiene R, et al. European Crohn's and Colitis Organisation (ECCO). European evidence based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. J Crohns Colitis 2008; 2:1-23. (Pubitemid 351179487)
24. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005;19 (Suppl A):5-36.
25. WHO, UNICEF, UNU. Iron Deficiency Anemia: Assessment, Prevention and Control. A guide for programme managers. Geneva: WHO reference number: WHO/NHD/01.3, WHO publications; 2001. p. 33.
26. Ganz T. Hepcidin and its role in regulating systemic iron metabolism. In: Hematology 2006. The American Society of Hematology (ASH) Education Program Book. Washington, DC: ASH publications; 2006. pp. 29-35.
27. Fleming MD. The regulation of hepcidin and its effects on systemic and cellular iron metabolism. In: Hematology 2008. The American Society of Hematology (ASH) Education Program Book. Washington, DC: ASH publications; 2008. pp. 151-158.
28. Kemna E, Pickkers P, Nemeth E, Van der Hoeven H, Swinkels D. Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood 2005; 106:1864-1866. (Pubitemid 41208606)
29. Kroot JJC, Kemna EHJM, Bansal SS, Busbridge M, Campostrini N, Girelli D, et al. Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization. Haematologica 2009; 94:1748-1752.
30. Jayaranee S, Sthaneshwar P, Sokkalingam S. Serum prohepcidin concentrations in rheumatoid arthritis. Pathology 2009; 41:178-182.
31. Kemna EH, Kartikasari AE, Van Tits LJ, Pickkers P, Tjalsma H, Swinkels DW. Regulation of hepcidin: insights from biochemical analyses on human serum samples. Blood Cells Mol Dis 2008; 40: 339-346. (Pubitemid 351508446)
32. Valore E, Ganz T. Posttranslational processing of hepcidin in human hepatocytes is mediated by the prohormone convertase furin. Blood Cells Mol Dis 2008; 40:132-138. (Pubitemid 350192311)
33. Beirão I, Almeida S, Swinkels D, Costa PM, Moreira L, Fonseca I, et al. Low serum levels of prohepcidin, but not hepcidin-25, are related to anemia in familial amyloidosis TTR V30M. Blood Cells Mol Dis 2008; 41:175-178.